Literature DB >> 29430452

How to improve quality of research in intensive care medicine.

Marcus J Schultz1,2, Lieuwe D Bos2,3, Arjen M Dondorp1,2.   

Abstract

This paper discusses several approaches to improve quality of research in intensive care medicine. The baseline standard of care is important in randomized controlled trials. If standard of care is low, trialists could consider improving this before starting the trial. Implementation studies and efficacy trials should not be mixed up. Trialists could further try to increase prognostic as well as predictive enrichment, e.g., through biological phenotyping. Robustness of statistical findings can increase by enrolling sufficiently high numbers of patients and minimizing loss to follow-up.

Entities:  

Keywords:  Intensive care; fragility index (FI); population enrichment; statistics; study design

Year:  2018        PMID: 29430452      PMCID: PMC5799141          DOI: 10.21037/atm.2018.01.18

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  14 in total

1.  Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition.

Authors:  Russell E Glasgow; Edward Lichtenstein; Alfred C Marcus
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

2.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

Review 3.  Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design.

Authors:  Hallie C Prescott; Carolyn S Calfee; B Taylor Thompson; Derek C Angus; Vincent X Liu
Journal:  Am J Respir Crit Care Med       Date:  2016-07-15       Impact factor: 21.405

4.  Why have clinical trials in sepsis failed?

Authors:  John C Marshall
Journal:  Trends Mol Med       Date:  2014-02-24       Impact factor: 11.951

Review 5.  The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index.

Authors:  Michael Walsh; Sadeesh K Srinathan; Daniel F McAuley; Marko Mrkobrada; Oren Levine; Christine Ribic; Amber O Molnar; Neil D Dattani; Andrew Burke; Gordon Guyatt; Lehana Thabane; Stephen D Walter; Janice Pogue; P J Devereaux
Journal:  J Clin Epidemiol       Date:  2014-02-05       Impact factor: 6.437

6.  Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.

Authors:  Katie R Famous; Kevin Delucchi; Lorraine B Ware; Kirsten N Kangelaris; Kathleen D Liu; B Taylor Thompson; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

Review 7.  The Fragility Index in Multicenter Randomized Controlled Critical Care Trials.

Authors:  Elliott E Ridgeon; Paul J Young; Rinaldo Bellomo; Marta Mucchetti; Rosalba Lembo; Giovanni Landoni
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

8.  Drotrecogin alfa (activated) in adults with septic shock.

Authors:  V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Simon Finfer; Bengt Gårdlund; John C Marshall; Andrew Rhodes; Antonio Artigas; Didier Payen; Jyrki Tenhunen; Hussein R Al-Khalidi; Vivian Thompson; Jonathan Janes; William L Macias; Burkhard Vangerow; Mark D Williams
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

9.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.

Authors:  Roy G Brower; Paul N Lanken; Neil MacIntyre; Michael A Matthay; Alan Morris; Marek Ancukiewicz; David Schoenfeld; B Taylor Thompson
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

10.  Effect of a Quality Improvement Intervention With Daily Round Checklists, Goal Setting, and Clinician Prompting on Mortality of Critically Ill Patients: A Randomized Clinical Trial.

Authors:  Alexandre B Cavalcanti; Fernando Augusto Bozza; Flavia R Machado; Jorge I F Salluh; Valquiria Pelisser Campagnucci; Patricia Vendramim; Helio Penna Guimaraes; Karina Normilio-Silva; Lucas Petri Damiani; Edson Romano; Fernanda Carrara; Juliana Lubarino Diniz de Souza; Aline Reis Silva; Grazielle Viana Ramos; Cassiano Teixeira; Nilton Brandão da Silva; Chung-Chou H Chang; Derek C Angus; Otavio Berwanger
Journal:  JAMA       Date:  2016-04-12       Impact factor: 56.272

View more
  1 in total

Review 1.  Fragility Index in Cardiovascular Randomized Controlled Trials.

Authors:  Muhammad Shahzeb Khan; Rohan Kumar Ochani; Asim Shaikh; Muhammad Shariq Usman; Naser Yamani; Safi U Khan; M Hassan Murad; John Mandrola; Rami Doukky; Richard A Krasuski
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.